LGND Ligand Pharmaceuticals
- 71.645
- +1.275+1.81%
Ligand Pharmaceuticals News
DEFA14A: Others
ARS: Annual Report to Security Holders
DEF 14A: Definitive information statements
8-K: Current report
Ligand Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Davis Todd C
Ligand Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Sabba Stephen L
Ligand Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Aryeh Jason
Ligand Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Ligand Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Ligand Pharmaceuticals | 10-K: Annual report
Ligand Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Reardon Andrew
Ligand Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Korenberg Matthew E
Ligand Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Espinoza Octavio
Ligand Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Davis Todd C
Ligand Pharmaceuticals | 144/A: Others
Ligand Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Ligand Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Ligand Pharmaceuticals | 8-K: Ligand Reports Fourth Quarter and Full Year 2023 Financial Results
Ligand Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Reardon Andrew
Ligand Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Korenberg Matthew E
Analysis
Price Target
No Data
